Xentria, Inc.
Tom Shea is an accomplished executive with extensive experience in the pharmaceutical industry. Currently serving as Chief Executive Officer at Xentria, Inc. and Meitheal Pharmaceuticals, Inc., Tom has a history of leadership in various management roles, including Vice President of Global Alliance Management and Project and Product Management at Sagent Pharmaceuticals. Previous positions include Director of Portfolio Management and National Account Manager at APP Pharmaceuticals, as well as multiple managerial roles at Fougera. Tom holds a Master of Business Administration (M.B.A.) from the University of Notre Dame's Mendoza College of Business and a Bachelor’s Degree from Marquette University.
Xentria, Inc.
Xentria is a venture studio that provides capital and insight into breakthrough science that aligns with our core therapeutic areas to improve the lives of patients and their families. Since our formation in 2020, we've forged authentic partnerships to advance challenging drug development, addressing unmet needs with increased collaboration, tenacity, and partnership. We offer holistic support, enhanced operational efficiency, and long-term partnerships to drive growth and assist in navigating challenges for an increased chance of success.